Landbridge Corporation: Raymond James raises target price to $91 from $90
LB•Raymond James raised its target price for Landbridge Corporation to $91 from $90.
Related News
RedHill partner wins $2.9 million NCI grant for opaganib-CAR T trials in multiple myeloma
RDHL•
Doximity, Inc.: Jefferies raises target price to $29 from $20
DOCS•
High Roller Technologies' Flip Pidot joins Senate prediction panel at NEXTPredict
ROLR•
Jefferies cuts Teladoc Health target price to $6 from $8
TDOC•
MKS agrees to sell Ophir Optics business to TTM Technologies for $650 million
MKSI•